Publications

  • Interpersonal Connections Are Important for Virtual Kidney Transplant Educational Program Development [published online ahead of print, 2023 Nov 7]. Prog Transplant. 2023;15269248231212905.
    • Carter AJ, Qu H, Reed RD, Cozette Killian A, Kumar V, Hanaway M, Locke JE.
  • Non-invasive evaluation of hepatic macrosteatosis in deceased donors.
    • Frey KL, McLeod MC, Cannon RM, Sheikh SS, Purvis JW, Locke JE, Orandi BJ. Am J Surg. 2023;226(5):692-696.
  • A call to action in thoracic transplant surgical training.
    • Siddique A, Parekh KR, Huddleston SJ, Shults A, Locke JE, Keshavamurthy S, Schwartz G, Hartwig MG, Whitson BA. J Heart Lung Transplant. 2023;42(11):1627-1631.
  • Treatment Location Variation for Chronic Limb-Threatening Ischemia in Patients With Kidney Failure [published online ahead of print, 2023 Oct 6].
    • Rakestraw SL, Novak Z, Wang M, Banks CA, Spangler EL, Levitan EB, Locke JE, Beck AW, Sutzko DC. J Surg Res. 2023;293:300-306.
  • Normal Graft Function After Pig-to-Human Kidney Xenotransplant.
    • Locke JE, Kumar V, Anderson D, Porrett PM. JAMA Surg. 2023;158(10):1106-1108.
  • Social network interventions to reduce race disparities in living kidney donation: Design and rationale of the friends and family of kidney transplant patients study (FFKTPS).
    • Daw J, Verdery AM, Ortiz SE, Reed RD, Locke JE, Redfield RR 3rd, Kloda D, Liu M, Mentch H, Sawinski D, Aguilar D, Porter ND, Roberts MK, McIntyre K, Reese PP.  Clin Transplant. 2023;37(10):e15064.
  • HRSA’s Patient-Centric Approach to Modernizing the US Transplant System [published online ahead of print, 2023 Sep 27].
    • Doby BL, Knechtle SJ, Locke JE. JAMA Surg. 2023;10.1001
  • Regional Social Vulnerability is Associated with Geographic Disparity in Waitlist Outcomes for Patients with Non-HCC MELD Exceptions in the United States [published online ahead of print, 2023 Sep 27].
    • Cannon RM, Goldberg DS, Sheikh SS, Anderson DJ, Pozo M, Rabbani U, Locke JE. Ann Surg. 2023;10.1097
  • Differences in Long-Term Outcomes in End-Stage Kidney Disease Patients with Chronic Limb-Threatening Ischemia.
    • Rakestraw SL, Novak Z, Wang MY, Banks CA, Spangler EL, Levitan EB, Locke JE, Beck AW, Sutzko DC. Ann Vasc Surg. 2023;95:162-168.
  • African American/black race, Apolipoprotein L1, and the indirect glomerular filtration measure serum creatinine among persons living with HIV [published online ahead of print, 2023 Aug 31].
    • Shelton BA, Sawinski D, Peter I, Maclennan PA, Pelletier NF, Nadkarni G, Julian B, Saag M, Fatima H, Crane H, Lee W, Moore RD, Christopoulos K, Jacobson JM, Eron JJ, Kumar V, Locke JE. AIDS. 2023;10.1097
  • Racial Disparities in Access to the Kidney Transplant Waitlist Among People with Human Immunodeficiency Virus.
    • Shelton BA, Becker DJ, MacLennan PA, Sen B, Budhwani H, Locke JE. AIDS Patient Care STDS. 2023;37(8):394-402.
  • A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States.
    • Liapakis A, Agbim U, Bittermann T, Dew MA, Deng Y, Gan G, Emre S, Hunt HF, Olthoff KM, Locke JE, Jesse MT, Kumar V, Pillai A, Verna E, Lentine KL. Clin Transplant. 2023;37(7)
  • Living donor liver transplantation: a multi-disciplinary collaboration toward growth consensus, and a change in culture.
    • Liapakis A, Jesse MT, Pillai A, Bitterman T, Dew MA, Emre S, Hunt H, Kumar V, Locke JE, Mohammad S, Olthoff K, Verna EC, Lentine KL. Clinical Transplantation, 2023 February 26, 2023, accepted for publication.
  • Association of FDA mandate limiting acetaminophen (paracetamol) in prescription combination opioid products and subsequent hospitalizations and acute liver failure.
    • Orandi BJ, McLeod MC, MacLennan PA, Lee WM, Fontana RJ, Karvellas C, McGuire BM, Lewis CE, Terrault NM, Locke JE. JAMA, 2023 February 9, accepted for publication.
  • It is time for the light to shine on organ procurement organizations.
    • Cannon RM and Locke JE. JAMA Surgery, 2023 February 8, accepted for publication.
  • Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization.
    • Lentine KL, Tanaka T, Xiao H, Bittermann T, Dew MA, Schnitzler MA, Olthoff KM, Locke JE, Emre S, Hunt HF, Liapakis A, Axelrod DA. Clinical Transplantation, 2023 January 19, accepted for publication.
  • Making the Cut: Parathyroidectomy Before or After Kidney Transplantation?
    • Wang R, Saad F, McLeod MC, Kew C, Agarwal G, Wille K, Locke JE, Chen H, Ong S. World J Surg. 2023;47(2):319-329.
  • Spatiotemporal immune atlas of the first clinical-grade, gene-edited pig-to-human kidney xenotransplant.
    • Cheung MD, Asiimwe R, Erman EN, Fucile CF, Liu S, Sun CW, Hanumanthu VS, Pal HC, Wright ED, Ghajar-Rahimi G, Epstein D, Orandi BJ, Kumar V, Anderson DJ, Greene ME, Bell M, Yates S, Moore KH, LaFontaine J, Killian JT Jr, Baker G, Perry J, Reed R, Little SC, Rosenberg AF, George JF, Locke JE, Porrett PM. Preprint. Res Sq. 2023;rs.3.rs-2382345. Published 2023 Jan 9.
  • Access to the kidney transplant waitlist for people with HIV.
    • Shelton BA, MacLennan PA, Becker DJ, Bisakha S, Budhwani H, Locke JE. Transplantation, 2023 January 7, accepted for publication.
  • Progress towards solving the donor organ shortage.
    • Anderson DJ and Locke JE. . Nature Reviews Nephrology, 2022 November 22, accepted for publication.
  • Diabetes-free survival among living kidney donors and non-donors with obesity: a longitudinal cohort study.
    • Killian ACK, Reed RD, McLeod MC, MacLennan PA, Kumar V, Pittman SE, Maynor AG, Stanford LA, Baker GA, Schinstock CA, Silkensen JR, Roll GR, Segev DL, Orandi BJ, Lewis CE, Locke JE. PLOS ONE, 2022 October 14, accepted for publication.
  • RE-AIMing the focus on health equity in surgery.
    • Reed RD and Locke JE. Annals of Surgery, 2022 September 23, accepted for publication.
  • Reclassification of CKD in living kidney donors with the refitted eGFR formula.
    • Orandi BJ, McLeod C, Reed RD, Kumar V, Cannon RM, Lewis CE, Locke JE. AJS, 2022 September 18, accepted for publication.
  • Female birth sex is associated with increased risk of chronic kidney disease development among people with HIV: a longitudinal cohort study.
    • Shelton BA, Sawinski D, MacLennan PA, Lee W, Wyatt C, Nadkarni G, Fatima H, Mehta S, Crane HM, Porrett P, Julian B, Moore RD, Christopoulos K, Jacobson JM, Muller E, Eron JJ, Saag M, Peter I, Locke JE. eClinical Medicine, 2022 August 30, accepted for publication.
  • Reducing racial disparities in access to transplant in the United States: One step at a time.
    • Reed RD and Locke JE. CJASN, 2022 August 18, accepted for publication.
  • Change in Body Mass Index and Attributable Risk of New Onset Hypertension among Obese Living Kidney Donors.
    • Reed RD, McLeod MC, MacLennan PA, Kumar V, Pittman SE, Maynor AG, Stanford LA, Baker GA, Schinstock CA, Silkensen JR, Roll GR, Segev DL, Orandi BJ, Lewis CE, Locke JE. Annals of Surgery, 2022 July 27, accepted for publication.
  • Impact of refitted eGFR formula on obesity pharmacotherapy options.
    • Orandi BJ, McLeod C, Reed RD, Kumar V, Cannon RM, Lewis CE, Locke JE. Obesity, 2022 June 27, accepted for publication.
  • COVID-19 vaccination and remdesiver are associated with protection from new or increased levels of donor-specific antibodies among kidney transplant recipients hospitalized with COVID-19.
    • Killian JT, Houp JA, Burkholder GA, Roman Soto SA, Killian AC, Ong SC, Erdmann NB, Goepfert PA, Hauptfeld-Dolejsek V, Leal SM, Zumaquero E, Nellore A, Agarwal G, Kew CE, Orandi BJ, Locke JE, Porrett PM, Levitan EB, Kumar V, Lund FE. Transplant International, 2022 June 20, accepted for publication.
  • Perpetuating disparity: failure of the kidney transplant system to provide the most kidney transplants to communities in greates need.
    • Cannon RM, Anderson DJ, MacLennan P, Orandi BJ, Sheikh S, Kumar V, Hanaway MJ, Locke JE. Annals of Surgery, 2022 May 19, accepted for publication.
  • Lost potential and missed opportunities for DCD liver transplantation in the United States.
    • Cannon RM, Nassel AF, Walker JT, Sheikh SS, Orandi BJ, Lynch RJ, Shah MB, Goldberg DS, Locke JE. American Journal of Surgery, 2022 May 3, accepted for publication.
  • Greater community vulnerability may limit living donor navigator program engagement.
    • Killian AC, Carter AJ, Reed RD, Shelton BA, Qu H, Locke JE. Surgery, 2022 May 1, accepted for publication.
  • COVID-19 and transplantation – data censoring.
    • Subramanian V, Dhanireddy K, Karp S, Pastan S, Anderson C, Gerber D, Locke JE, Cohen A, Shah M, Casingal V, Strata R, Singh N, DuBay D. American Journal of Transplantation, 2022 April 19, accepted for publication.
  • Efficacy of HOPE: analysis of organ quality and availability among deceased HIV-positive donors.
    • Woods C, Owens GE, Shelton BA, MacLennan PA, Sawinski D, Jacobson JA, Locke JE. Transplant Infectious Diseases, 2022 April 16, accepted for publication.
  • The science of xenotransplantation for nephrologists.
    • Hansen-Estruch C, Porrett PM, Kumar V, Locke JE. Current Opinion in Nephrology and Hypertension, 2022 April 5, accepted for publication.
  • Editorial: A sex-adjusted MELD-Na score for equality in liver transplantation.
    • Shelton BA and Locke JE. JAMA Surgery, 2022 April 3, accepted for publication.
  • County level differences in liver-related mortality, waitlisting, and liver transplantation in the United States.
    • Cannon RM, Nassel A, Walker JT, Sheikh SS, Orandi BJ, Shah MB, Lynch RJ, Goldberg DS, Locke JE. Transplantation, 2022 March 20, accepted for publication.
  • Patient-reported barriers to living kidney donor follow-up.
    • Orandi BJ, Reed R, Qu H, Owens G, Brooks S, Killian AC, Kumar V, Sheikh SS, Cannon RM, Anderson DJ, Lewis CE, Locke JE. Clinical Transplantation, 2022 February 9, accepted for publication.
  • Abnormal time-zero histology is predictive of kidney transplant outcomes.
    • Seifert ME, Agarwal G, Anderson DJ, Fatima H, Hanaway M, Locke JE, MacLennan P, Orandi BJ, Young C, Mannon R.
  • Patient survival following third time liver transplant in the United States in the MELD era.
    • He K, Sheikh SS, Orandi BJ, Smith B, Locke JE, Cannon RM. November 14, accepted for publication.
  • Patient survival following third time liver transplant in the United States in the MELD era.
    • Kai H, Sheikh SS, Orandi BJ, Smith B, Locke JE, Cannon RM. The American Journal of Surgery, 2021 October 31, accepted for publication.
  • Editorial: Sensitization and desensitization in organ transplantation.
    • Anwar IJ, Jackson AM, Locke JE, Kwun J. Frontiers in Immunology, 2021 October 14, accepted for publication.
  • A retrospective cohort study of dialysis non-adherence and kidney transplant outcomes.
    • Sawinski D, Linder H, Schults J, Locke JE, Cohen JB, MacLennan PA, Reese PP. American Journal of Kidney Disease, 2021 September 30, accepted for publication.
  • Hepatic macrosteatosis in the U.S. pediatric deceased donor liver population.
    • Purvis JW, Orandi BJ, Dhall D, McLeod C, Gutierrez Sanchez LH, Gray M, Frey K, Sheikh S, Cannon R, Terrault N, Lewis CE, Locke JE. Pediatric Transplantation, 2021 September 19, accepted for publication.
  • Addressing ethical confusion in deceased donation and transplantation research: the need for dedicated guidance.
    • Martin DE, Cronin AJ, Ave AD, van Haren FMP, Locke JE, Minambres E, Oniscu GC, Parent B. Transplant International, 2021 September 10, accepted for publication.
  • Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation.
    • Locke JE, Shelton B, Orandi B, Olthoff K, Pomfret E, Forde KA, Sawinski D, Gray M, Ascher N. Clinical Transplantation, 2021; 35(7)
  • Impact of social vulnerability on access to educational programming designed to enhance living donation.
    • Carter AJ, Reed RD, Killian AC, Hendricks DH, Baldwin KN, Qu H, Kumar V, Hanaway MJ, Cannon RM, Locke JE. Progress in Transplantation, 2021 July 12, accepted for publication.
  • Living donor kidney transplantation racial disparities persist independent of community vulnerability.
    • Killian AC, Shelton BA, MacLennan PA, Reed RD, McLeod MC, Qu H, Orandi BJ, Kumar V, Sawinski D, Cannon RM, Anderson D, Hanaway M, Locke JE. JAMA Surgery, 2021 July 11, accepted for publication.
  • Acute liver failure in a healthy young female with COVID-19.
    • Orandi BJ, Li G, Dhall D, Bajpai P, Manne U, Arora N, Lu A, Coronado AC, Kassel R, Pinninti S, Lewis CE, Locke JE, Gutierrez Sanchez LH. JPGN Reports, 2021 June 14, accepted for publication.
  • Cognitive mapping as an approach to facilitate organ donation among African Americans.
    • Locke JE, Reed RD, Shewchuk R, Stegner KL, Qu H. Science Progress, 2021 June 8, accepted for publication.
  • Optimal timing of administration of direct-acting antivirals for patients with hepatitis C-associated hepatocellular carcinoma undergoing liver transplantation.
    • Turgeon MK, Shah SA, Delman AA, Tran BV, Agopian VG, Wedd JP, Magliocca JF, Anderson MP, Kubal CA, Cannon RM, Locke JE, Simpson MA, Akoad ME, Wongijrad CP, Emamaullee J, Moro A, Aucejo F, Feizpour CA, Vaggefi PA, Nguyen MH, Esquivel MS, Dhanireddy K, Subramannian V, Anderson MA, Sonneday CJ, Moris D, Sudan DL, Abdouljod M, Salgia RJ, Ganesh SR, Humar A, Doyle M, Chapman WC, Maithel SK. Annals of Surgery (accepted to American Surgical Association 141st Meeting), 2021 April 16, accepted for publication.
  • Eliminating hepatitis C virus from the hemodialysis population: a micro-elimination approach review.
    • Bell EK, Towns GC, Franco RA, Rajasekaran A, Locke JE, McGuire BM. Kidney International Reports, 2021 April 12, accepted for publication.
  • Obesity as an isolated contraindication to kidney transplantation in the end-stage renal disease population.
    • Orandi BJ, Lewis CE, MacLennan PA, Qu H, Mehta S, Kumar V, Sheikh SS, Cannon RM, Anderson DJ, Hanaway MJ, Reed RD, Kale AC, Purvis JW, Terrault NA, Locke JE. Obesity, 2021 April 11, accepted for publication.
  • Conveying significance and innovation in grant proposals.
    • Hunter CJ, Locke JE, Cho CS, Goldstein AM, Gosain A. Surgery, 2021 March 8, accepted for publication.
  • APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).
    • Kumar V and Locke JE. Kidney International, 2021 February 18, accepted for publication.
  • Survival following simultaneous liver-lung versus liver alone transplantation: results of the US national experience.
    • Purvis J, McLeod C, Smith B, Kale AC, Orandi BJ, Locke JE, Eckhoff DE, Cannon RM. American Journal of Surgery, 2021 January 31, accepted for publication.
  • Early outcomes with the liver-kidney safety net.
    • Cannon RM, Goldberg DS, Eckhoff DE, Anderson DJ, Orandi BJ, Locke JE. Transplantation, 2021; 105(6): 1261-1272.
  • Outcomes associated with de novo donor specific antibody development in simultaneous pancreas-kidney transplantation.
    • Ladwoski J, Mullins H, Romine M, Kloda D, Young C, Hauptfeld-Dolejsek V, Houp J, Locke JE. Human Immunology, 2020 December 27, accepted for publication.
  • Self-advocacy is associated with lower likelihood of living donor kidney transplantation.
    • Killian AC, Reed RD, Carter A, McLeod MC, Shelton BA, Kumar V, Qu H, MacLennan PA, Orandi BJ, Cannon RM, Anderson D, Hanaway MJ, Locke JE. American Journal of Surgery. 2020 December 20, accepted for publication.
  • RE: Justice in Allocation – Leveraging frailty to mitigate sex-based disparities in access to liver transplantation.
    • Sheikh S and Locke JE. JAMA Surgery, October 31, 2020, accepted for publication.
  • Integrating APOL1 kidney risk variant testing into live kidney donor evaluation – guidelines from the American Society of Transplantation’s Living Donor Community of Practice.
    • Doshi M, Locke JE, Gordon E, Freedman B, Glover C, Thomas C. Transplantation, 2020 December 18, accepted for publication.
  • What therapeutic regimen will be optimal for initial clinical trials of pig organ transplantation.
    • Bikhet M, Iwase H, Yamamoto T, Jagdale A, Foote JB, Eelarab M, Anderson DJ, Locke JE, Eckhoff DE, Hara H, Cooper DKC. Transplantation, 2020 December 3, accepted for publication.
  • Analysis of culturally targeted initiatives in websites of kidney transplant programs in the United States between 2013-2018.
    • Brooks JT, Shelton B, Reed RD, Nino L, Benavides X, Ortiz J, Locke JE, Caicedo JC. Progress in Transplantation, 2020 December, accepted for publication.
  • Patient selection for initial clinical trials of pig kidney xenotransplantation.
    • Jagdale A, Kumar V, Hanaway MJ, Anderson DJ, Locke JE, Eckhoff DE, Cooper DKC. Transplantation, 2020 November 1, accepted for publication.
  • Pig kidney xenotransplantation: progress toward clinical trials.
    • Cooper DKC, Hara H, Iwase H, Yamamoto T, Wang Z, Jagdale A, Bikhet MH, Nguyen HQ, Foote JB, Paris WD, Ayares D, Kumar V, Anderson DJ, Locke JE, Eckhoff DE. Clinical Transplantation, 2020 October 27, accepted for publication.
  • Letter in reply (to Glazier and Wilk).
    • Hanaway M, MacLennan PA, Locke JE. JAMA Surgery, 2020 September 27, accepted for publication.
  • Human Immunodeficiency Virus from life taking to life giving: expanding the donor pool by using HIV-positive donors.
    • Mehta S and Locke JE. Current Opinion in Organ Transplantation, 2020 September 23, accepted for publication.
  • The living donor navigator program provides support tools for caregivers.
    • Reed RD, Kale AC, Mustian MN, Hendricks DH, Baldwin KN, Kumar V, Dionne-Odom N, Saag K, Hites L, Ivankova NV, Locke JE. Progress in Transplantation, 2020 September 15, accepted for publication.
  • Pre-existing melanoma and hematological malignancies, prognosis and timing to solid organ transplantation: a consensus expert opinion statement.
    • Al-Aldra D, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Berna E, Locke JE, D’Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta P, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qauod, Eggener S, Richegels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. American Journal of Transplantation, 2020 September 10, accepted for publication.
  • Pre-existing solid organ malignancy, prognosis and timing to organ transplantation: a consensus expert opinion statement.
    • Al-Aldra D, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Berna E, Locke JE, D’Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta P, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qauod, Eggener S, Richegels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. American Journal of Transplantation, 2020 September 10, accepted for publication.
  • The tetraspanin CD151 marks a unique population of activated human T cells.
    • Perez M, Seu L, Moylan DC, Tidwell C, Lowman K, Samuel S, Duberger A, Wagner FH, Carlin E, Sharma V, Pope B, Raman C, Erdmann N, Locke JE, Hu H, Sabbaj S, Kutsch O. Scientific Reports, 2020 September 4, accepted for publication.
  • Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C-positive recipients in the direct-acting antiviral era: time to revise the kidney donor risk index?
    • Cannon RM, Locke JE, Orandi BJ, Anderson DJ, Davis EG, Mackelaite L, Dave H, Eng M, Jones CM. Transplantation, 2020; 104(6): 1215-1228.
  • Commentary on: “Outcomes in kidney transplantation between Veterans Affairs and civilian hospitals: considerations in the context of the MISSION Act.”
    • Locke JE. Annals of Surgery, 2020 May 12, accepted for publication.
  • Bariatric surgery to achieve transplant in end-stage organ disease patients: a systematic review and meta-analysis.
    • Orandi BJ, Purvis JW, Lewis CE, Terrault NM, Smith B, Cannon RM, Locke JE. American Journal of Surgery, 2020 April 30, accepted for publication.
  • Use of patient navigators to reduce barriers in living donation & living donor transplantation.  
    • Nishio-Lucar AG, Locke JE, and Kumar V. Current Transplant Reports, 2020 March 14, accepted for publication.
  • Cardiac mortality following kidney transplantation: progress made but still room for improvement.
    • Reed R and Locke JE. Transplantation, 2020 March 4, [Epub ahead of print].
  • Quantifying disparities in liver allocation: a path forward.
    • Locke JE, Shelton B, Olthoff K, Pomfret E, Sawinski D, Forde K, Gray M, Ascher N. JAMA Surgery, 2020; 155(7).
  • Exacerbating racial disparities in kidney transplantation: the untoward consequences of geographic redistribution.
    • Hanaway M, MacLennan PA, Locke JE. JAMA Surgery, 2020 June 3, [Epub ahead of print].
  • Tackling the weight list problem.
    • Orandi BJ and Locke JE. American Journal of Transplantation, 2020; 20(2): 329-330.
  • A qualitative assessment of the living donor navigator program: identifying core competencies and promising practices for implementation.
    • Reed RD, Hites L, Mustian MN, Shelton BA, Hendricks D, Berry B, MacLennan PA, Blackburn J, Wingate MS, Yates C, Hannon L, Kilgore ML, Locke JE. Progress in Transplantation, 2020; 30(1): 29-37.
  • Social determinants of health and racial disparities in kidney transplantation.
    • Reed RD and Locke JE. Transplantation, 2020; 104(7): 1324-1325.
  • Donor-recipient relationship and risk of ESKD in live kidney donors of varied racial groups.
    • Muzaale AD, Massie AB, Henderson ML, Purnell T, Ammary FA, Locke JE, Lentine KL, Segev DL. American Journal of Kidney Disease, 202; 75(3): 333-341.
  • Regional variation in the appropriateness of non-HCC MELD exceptions.
    • Cannon RM, Davis EG, Goldberg DS, Lynch RJ, Shah MB, Locke JE, McMasters KM, Jones CM. Journal of the American College of Surgeons, 2020; 230(4): 503-512.
  • Impact of donor hepatitis C virus on kidney transplant outcomes in the direct acting antiretroviral era: time to revise the kidney donor risk index?
    •  Cannon RM, Locke JE, Orandi BJ, Anderson DJ, Davis EG, Mackelaite L, Dave H, Eng M, Jones CM. Transplantation, 2020; 104(6): 1215-1228.
  • Self-reported incident hypertension and long-term renal function in living kidney donors compared to healthy non-donors.
    • Holscher CM, Haugen CE, Jackson KR, Garonzik-Wang JM, Waldram MM, Bae S, Scharfstein DO, Locke JE, Reed RD, Lentine KL, Gupta G, Weir MR, Friedewald JJ, Verbesey J, Cooper M, Segev DL, Massie AB. Clinical Journal of the American Society of Nephrology, 2019; 14(10): 1493-1499.
  • Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome.
    Mustian MN, Kumar V, Hanaway M, MacLennan PA, Shelton BA, Reed RD, Correya T, Grant R, Carter A, Baker G, Patterson J, Peoples M, Holden S, Orandi BJ, Locke JE. Surgery. 2019 Aug 20

  • Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation’s Longest Single-center Kidney Chain. Mustian MN, Kumar V, Stegner K, Mompoint-Williams D, Hanaway M, Deierhoi MH, Young C, Orandi BJ, Anderson D, MacLennan PA, Reed RD, Shelton BA, Eckhoff D, Locke JE. Ann Surg. 2019 Jul 24

  • Patient Perspectives on Weight Management for Living Kidney Donation. Mustian MN, Hanaway M, Kumar V, Reed RD, Shelton BA, Grant R, Carter A, Locke JE. J Surg Res. 2019 Jul 3

  • Center Variation and Risk Factors for Failure to Complete 6 Month Postdonation Follow-up Among Obese Living Kidney Donors. Reed RD, MacLennan PA, Shelton BA, Mustian MN, Blackburn J, Smith SC, Terry KB, Grant R, Sawinski D, Locke JE. Transplantation. 2019 Jul

  • CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients. Yanik MV, Seifert ME, Locke JE, Hauptfeld-Dolejsek V, Crowley MR, Cutter GR, Mannon RB, Feig DI, Limdi NA. Pediatr Transplant. 2019 Aug

  • Get on with it!-A novel allocation strategy to reduce kidney discards. Locke JE, Sellers MT. Am J Transplant. 2019 May 23

  • Obesity and long-term mortality risk among living kidney donors. Locke JE, Reed RD, Massie AB, MacLennan PA, Sawinski D, Kumar V, Snyder JJ, Carter AJ, Shelton BA, Mustian MN, Lewis CE, Segev DL. Surgery. 2019 Aug

  • Time for reform in transplant program-specific reporting: AST/ASTS transplant metrics taskforce. Chandraker A, Andreoni KA, Gaston RS, Gill J, Locke JE, Mathur AK, Norman DJ, Patzer RE, Rana A, Ratner LE, Schold JD, Pruett TL; AST/ASTS Transplant Metrics Taskforce. Am J Transplant. 2019 Jul

  • Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation. Locke JE, Reed RD, Kumar V, Berry B, Hendricks D, Carter A, Shelton BA, Mustian MN, MacLennan PA, Qu H, Hannon L, Yates C, Hanaway MJ. Transplantation. 2019 Apr 1

  • Kidney Transplantation in a HIV-Positive Recipient. Sawinski D, Locke JE.Clin J Am Soc Nephrol. 2019 Apr 5

  • Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study. Sawinski D, Forde KA, Lo Re V 3rd, Goldberg DS, Cohen JB, Locke JE, Bloom RD, Brensinger C, Weldon J, Shults J, Reese PP. Am J Kidney Dis. 2019 Jun

  • Patient-reported outcome measures for life participation in kidney transplantation: A systematic review. Ju A, Chow BY, Ralph AF, Howell M, Josephson MA, Ahn C, Butt Z, Dobbels F, Fowler K, Jowsey-Gregoire S, Jha V, Locke JE, Tan JC, Taylor Q, Rutherford C, Craig JC, Tong A. Am J Transplant. 2019 Aug

  • Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant. Shelton BA, Berdahl G, Sawinski D, Linas BP, Reese PP, Mustian MN, Reed RD, MacLennan PA, Locke JE. Am J Transplant. 2019 Jun

  • Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus. Cohen JB, Locke JE, Shelton B, Reed RD, Mustian M, MacLennan P, Forde KA, Reese PP, Sawinski D. Clin Transplant. 2019 Feb

  • Critical Appraisal of International Clinical Practice Guidelines in Kidney Transplantation Using the Appraisal of Guidelines for Research and Education II Tool: A Systematic Review. OʼDonoghue KJM, Reed RD, Knight SR, OʼCallaghan JM, Ayaz-Shah AA, Hassan S, Weissenbacher A, Morris PJ, Pengel LHM. Transplantation. 2018 Sep;102(9):1419-1439.

  • Can you hear me now? Patient Preferences for Evaluating Kidney Transplant Centers. Sawinski D, Locke JE. Am J Transplant. 2018 Aug 9

  • Expand the Pool of Living Donors for Kidney Transplantation. Locke JE. Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1142-1143.

  • Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates. Martins PN, Mustian MN, MacLennan PA, Ortiz JA, Akoad M, Caicedo JC, Echeverri GJ, Gray SH, Lopez-Soler RI, Gunasekaran G, Kelly B, Mobley CM, Black SM, Esquivel C, Locke JE. Am J Transplant. 2018 Mar 6. doi: 10.1111/ajt.14719. 

  • Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates. Mustian MN, Shelton BA, MacLennan PA, Reed RD, White JA, Eckhoff DE, Locke JE, Allman RM, Gray SH. Transplantation. 2019 Jul

  • Population level outcomes and cost-effectiveness of Hepatitis C treatment pre versus post kidney transplant. Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE. Am J Transplant. 2018 Jul 30.
Pages: Page 1, Page 2, Page 3, Page 4, Page 5